lonsn
In 2022, Smith & Nephew’s (LON:SN) like for like revenues were up 4.7% to $5.2bn, ignoring currency movements. This was helped by improved trading in the final quarter across all divisions, with Sports Medicine & ENT (Ear Nose and Throat) performing particularly strongly. A 4.1% increase in fourth quarter Orthopaedics revenues was driven by a return to growth in hip implants and a 5.5% increase in knee implant sales, where momentum in new products continues to build. Q4 2022 hedge fund letters, conferences and more Despite the higher revenues, trading profit (underlying operating profit) was d...
ValueWalk
Investments to consider for a Stocks and Shares ISA, ahead of the ISA deadline on 5th April. 3 stocks3 investment trusts3 fundsSophie Lund-Yates, Lead Equity Analyst, Hargreaves Lansdown: “Choosing shares, investment trusts or funds in the current environment is an especially difficult task. The Ukraine crisis, soaring inflation and the resulting lower investor confidence mean it’s more important than ever to make sure you have a diversified portfolio. For share investors it’s a good time to consider investing in companies that offer vital products or services as those with evergreen demand te...
ValueWalk
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら